Waist circumference as a predictor of ischemic heart disease in patients with type 2 diabetes mellitus

Authors

Keywords:

ischemic heart disease, type 2 diabetes mellitus, waist circumference

Abstract

Introduction: Waist circumference is the best clinical indicator of abdominal visceral fat and is valuable for establishing a prognosis for comorbidities.

Objective: To determine the cutoff point for waist circumference as a predictor of ischemic heart disease in patients with type 2 diabetes mellitus.

Methods: A case-control analytical study was conducted in patients with type 2 diabetes mellitus treated at the Bayamo Diabetes Care Center, Granma province, Cuba, from January 1, 2015, to December 31, 2020. Sensitivity, specificity, and positive and negative predictive values ​​were calculated for each waist circumference cutoff point.

Results: The optimal waist circumference cutoff point for men was 100 cm with a sensitivity of 75.0%, a specificity of 75.6%, a positive predictive value of 56.25%, and a negative predictive value of 87.8% (area under the ROC curve = 0.753; 95% confidence interval = 0.684–0.822; p = 0.000). For women, the cutoff point was 99 cm with a sensitivity of 56.9%, a specificity of 77.4%, a positive predictive value of 64.4%, and a negative predictive value of 71.4% (area under the ROC curve = 0.672; 95% confidence interval = 0.602–0.742; p = 0.000).

Conclusions: A waist circumference of 100 cm in men and 99 cm in women is a predictor of ischemic heart disease in patients with type 2 diabetes mellitus.

Downloads

Download data is not yet available.

References

1. Sumińska M, Podgórski R, Bogusz-Górna K, Skowrońska B, Mazur A, Fichna M. Historical and cultural aspects of obesity: From a symbol of wealth and prosperity to the epidemic of the 21st century [Internet]. Obes Rev. 2022;23(6):e13440. DOI: https://doi.org/10.1111/obr.13440

2. World Obesity Federation. World Obesity Atlas 2023 [Internet]. [acceso: 01/09/2024]. Disponible en: https://data.worldobesity.org/publications/?cat=19

3. Bonet Gorbea M, Varona Pérez P, Chang La Rosa M, García Rocha RG, Suárez Medina R, Arcia Montes de Oca N, et al. III Encuesta Nacional de factores de riesgo y actividades preventivas de enfermedades no transmisibles [Internet]. Cuba 2010-2011. La Habana: Editorial Ciencias Médicas; 2015. [acceso: 13/02/2024]. Disponible en: https://extranet.who.int/ncdccs/Data/CUB_C5_Encuesta_nacional_FR_2010-11.pdf

4. Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003-2018 [Internet]. Cardiovasc Diabetol. 2024;23(1):8. DOI: https://doi.org/10.1186/s12933-023-02115-9

5. Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association [Internet]. Circulation. 2021;143(21):e984-e1010. DOI: https://doi.org/10.1161/CIR.0000000000000973

6. Tao Z, Zuo P, Ma G. Association of weight-adjusted waist index with cardiovascular disease and mortality among metabolic syndrome population [Internet]. Sci Rep. 2024;14(1):18684. DOI: https://doi.org/10.1038/s41598-024-69486- 1

7. Zhao P, Du T, Zhou Q, Wang Y. Association of weight-adjusted-waist index with all-cause and cardiovascular mortality in individuals with diabetes or prediabetes: a cohort study from NHANES 2005-2018 [Internet]. Sci Rep. 2024;14(1):24061. DOI: https://doi.org/10.1038/s41598-024-74339-y

8. Zhong P, Tan S, Zhu Z, Zhu Z, Liang Y, Huang W, et al. Normal-weight central obesity and risk of cardiovascular and microvascular events in adults with prediabetes or diabetes: Chinese and British cohorts [Internet]. Diabetes Metab Res Rev. 2023;39(8):e3707. DOI: https://doi.org/10.1002/dmrr.3707

9. Qiao T, Luo T, Pei H, Yimingniyazi B, Aili D, Aimudula A, et al. Association between abdominal obesity indices and risk of cardiovascular events in Chinese populations with type 2 diabetes: a prospective cohort study [Internet]. Cardiovasc Diabetol. 2022;21(1):225. DOI: https://doi.org/10.1186/s12933-022-01670-x

10. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal Definition of Myocardial Infarction (2018) [Internet]. J Am Coll Cardiol. 2018;72(18):2231-2264. DOI: https://doi.org/10.1016/j.jacc.2018.08.1038

11. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes [Internet]. Eur Heart J. 2020;41(3):407-477. DOI: https://doi.org/10.1093/eurheartj/ehz425

12. American Diabetes Association Professional Practice Committee; 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022 [Internet]. Diabetes Care. 2022;45 (Supplement_1): S17–S38. DOI: https://doi.org/10.2337/dc22-S002

13. Mazumdar M, Glassman JR. Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments [Internet]. Stat Med. 2000;19(1):113-32. DOI: https://doi.org/10.1002/(sici)1097-0258(20000115)19:1<113::aid-sim245>3.0.co;2-o

14. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects [Internet]. JAMA. 2013;310(20):2191-4. DOI: https://doi.org/10.1001/jama.2013.281053

15. Arrieta F, Pedro-Botet J, Iglesias P, Obaya JC, Montanez L, Maldonado GF, et al. Diabetes mellitus y riesgo cardiovascular: actualización de las recomendaciones del Grupo de Trabajo de Diabetes y Enfermedad Cardiovascular de la Sociedad Española de Diabetes (SED), 2021 [Internet]. Clin Investig Arterioscler. 2022;34(1):36-55. DOI: https://doi.org/10.1016/j.arteri.2021.05.002

16. Magliano DJ, Chen L, Carstensen B, Gregg EW, Pavkov ME, Salim A, et al. Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data [Internet]. Lancet Diabetes Endocrinol. 2022;10(2):112-119. DOI: https://doi.org/10.1016/S2213-8587(21)00327-2

17. Hinnen D, Kruger D, Magwire M. Type 2 diabetes and cardiovascular disease: risk reduction and early intervention [Internet]. Postgrad Med. 2023 Jan;135(1):2-12. DOI: https://doi.org/10.1080/00325481.2022.2126235

18. Koskinas KC, Van Craenenbroeck EM, Antoniades C, Blüher M, Gorter TM, Hanssen H, et al. Obesity and cardiovascular disease: an ESC clinical consensus statement [Internet]. Eur Heart J. 2024;45(38):4063-4098. DOI: https://doi.org/10.1093/eurheartj/ehae508

19. Lopez-Jimenez F, Almahmeed W, Bays H, Cuevas A, Di Angelantonio E, le Roux CW, et al. Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation [Internet]. Eur J Prev Cardiol. 2022;29(17):2218-2237. DOI: https://doi.org/10.1093/eurjpc/zwac187

20. Tabary M, Cheraghian B, Mohammadi Z, Rahimi Z, Naderian MR, Danehchin L, et al. Association of anthropometric indices with cardiovascular disease risk factors among adults: a study in Iran [Internet]. Eur J Cardiovasc Nurs. 2021;20(4):358-366. DOI: https://doi.org/10.1093/eurjcn/zvaa007

21. Macek P, Biskup M, Terek-Derszniak M, Krol H, Smok-Kalwat J, Gozdz S, et al. Optimal cut-off values for anthropometric measures of obesity in screening for cardiometabolic disorders in adults [Internet]. Sci Rep. 2020;10(1):11253. DOI: https://doi.org/10.1038/s41598-020-68265-y

22. Darbandi M, Pasdar Y, Moradi S, Mohamed HJJ, Hamzeh B, Salimi Y. Discriminatory Capacity of Anthropometric Indices for Cardiovascular Disease in Adults: A Systematic Review and Meta-Analysis [Internet]. Prev Chronic Dis. 2020;17:E131. DOI: https://doi.org/10.5888/pcd17.200112

Downloads

Published

2026-01-27

How to Cite

1.
Valdés Ramos ER, Álvarez Aliaga A, Valdés Bencosme ER. Waist circumference as a predictor of ischemic heart disease in patients with type 2 diabetes mellitus. Rev. cuba. med. mil [Internet]. 2026 Jan. 27 [cited 2026 Jan. 29];55(1):e026076964. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/76964

Issue

Vol. 55 No. 1 (2026): January - March (In progress)

Section

Research Article

License

Copyright (c) 2026 Eduardo René Valdés Ramos, Alexis Álvarez Aliaga, Eduardo René Valdés Bencosme

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Authors who have publications with this Journal accept the following terms:

  • The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
  • The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
  • Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.